Runway Growth Announces $15 Million Share Repurchase Authorization
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 07 2026
0mins
"In the first quarter, Runway Growth focused on the close and integration of the SWK Holdings acquisition, while navigating a volatile macroeconomic backdrop," said David Spreng, Founder and CEO of Runway Growth. "With the transaction now complete, we are well positioned to selectively capitalize on opportunities and expand our exposure to leading healthcare and life sciences companies. Today, we also announced a new $15 million share repurchase authorization, which we expect to utilize as we believe our shares present an extremely compelling value relative to the outlook of the business."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RWAY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RWAY
Wall Street analysts forecast RWAY stock price to rise
7 Analyst Rating
2 Buy
5 Hold
0 Sell
Moderate Buy
Current: 6.530
Low
9.00
Averages
10.57
High
12.00
Current: 6.530
Low
9.00
Averages
10.57
High
12.00
About RWAY
Runway Growth Finance Corp. is a specialty finance company. The Company is focused on providing senior secured loans to high growth-potential companies in technology, healthcare, business services, financial services, select consumer services and products and other high-growth industries. Its investment objective is to maximize its total return to its stockholders primarily through current income on the Company's loan portfolio and secondarily through capital gain (loss) on its warrants and other equity positions. The Company invests in senior secured term loans and other senior debt obligations, and it also invests in second lien loans issued by high growth-potential companies. The Company originates its investments through two strategies: Sponsored Growth Lending and Non-Sponsored Growth Lending. It also invests in secured loans, and acquires equity securities as well, including warrants. The Company is externally managed by Runway Growth Capital LLC (RGC).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Venture Debt Emerges as a Pillar of Startup Ecosystem
- Significant Venture Debt Growth: In 2025, U.S. venture debt reached a record $68.8 billion, while annual deal volume remained stable at around 1,000 transactions, indicating the increasing strategic importance of venture debt within the startup ecosystem.
- Investment Concentration in AI: U.S. venture investments totaled $321.6 billion in 2025, with 63.5% of deal value concentrated in artificial intelligence, reflecting a market preference for high-quality companies and an emphasis on capital efficiency.
- Flexible Financing Tool: High-quality companies are increasingly using venture debt as a strategic financing tool to extend flexibility, preserve ownership, and support growth without overly relying on dilutive equity capital.
- Future Outlook: The report predicts that venture debt will continue to play a larger role in 2026 as equity markets remain concentrated, serving as an efficient means for companies to finance growth, highlighting venture debt's dual role as a source of discipline and strategic advantage.
See More
Runway Growth Finance Corp. Q1 2026 Earnings Insights
- Acquisition Integration Progress: Runway Growth successfully completed the SWK acquisition in Q1 2026, with CEO David Spreng stating that this transaction will enhance the company's position in healthcare and further diversify its portfolio, although it faces near-term pressure from non-accrual loans.
- Leadership Changes: The company announced several executive appointments, including JD Tamas as Managing Director of Healthcare and Life Sciences Investing and Avisha Khubani promoted to Chief Credit Officer, indicating a strategic focus on key areas and talent deployment.
- Financial Performance Overview: In the first quarter, total investment income was $29.5 million and net investment income was $10.6 million, despite facing non-accrual status for loans from Marley Spoon and BlueShift, which raised the risk rating to 2.67, reflecting pressure on the investment portfolio.
- Future Outlook and Dividend Policy: Management expects the SWK portfolio to begin positively impacting EPS in Q2, although the non-accrual effects from Marley Spoon and BlueShift will offset some earnings; the board will continue to evaluate future dividend policies to maintain stability.
See More
Runway Growth Finance Reports Q1 Highlights
- Net Investment Income: Runway Growth Finance reported a net investment income of $0.29 for Q1, indicating stability in portfolio management despite a complex market environment, thus maintaining positive returns.
- Portfolio Size: The total fair value of the investment portfolio reached $886.3 million as of the reporting date, reflecting effective capital allocation and enhancing the company's competitive position in the industry.
- Yield Performance: The dollar-weighted annualized yield on debt investments stood at 14.2%, demonstrating successful risk management and providing shareholders with attractive return expectations, thereby boosting investor confidence.
- Investment Activity: The company completed four investments totaling $17.6 million in both new and existing portfolio companies, showcasing its proactive investment strategy and keen market opportunity recognition, further driving business growth.
See More
Runway Growth Capital Expands Credit Leadership with Key Appointments
- Credit Leadership Enhancement: Avisha Khubani has been promoted to Chief Credit Officer, overseeing Runway's credit functions including portfolio monitoring and risk management, which is expected to enhance the execution of the company's credit strategy.
- Focus on Healthcare: John D. Tamas has been appointed as Managing Director, concentrating on the healthcare and life sciences sectors, aiming to expand the firm's industry capabilities and network through his extensive investment experience.
- Experienced Team: Khubani has worked at Runway for eight years, previously serving as Managing Director of Portfolio Analytics, bringing deep expertise in portfolio valuation and management, which is anticipated to further improve the quality of the company's investment decisions.
- Strategic Growth Objectives: Runway aims to support fast-growing companies by providing senior loans ranging from $10 million to $150 million, and the appointments of Khubani and Tamas are expected to facilitate this goal, driving the company's expansion in the healthcare and life sciences sectors.
See More
Runway Growth Finance Corp. to Release Q1 2026 Financial Results
- Earnings Release Schedule: Runway Growth Finance Corp. will release its Q1 2026 financial results after market close on May 7, 2026, providing investors with insights into its latest financial status and operational performance.
- Conference Call Details: The company will hold a conference call on the same day at 2:00 PM PT (5:00 PM ET) to discuss the financial results, requiring investors to register in advance to ensure timely information dissemination.
- Webcast Replay Availability: A replay of the webcast will be available two hours after the call and archived on the same webpage for 90 days, allowing investors who cannot participate live to access the information later.
- Company Background: Runway Growth is a specialty finance company focused on providing flexible capital solutions to late- and growth-stage companies, aiming to offer alternatives to equity financing and enhance their market competitiveness.
See More
Runway Growth Completes Acquisition of SWK Holdings, Expanding Healthcare Focus
- Acquisition Finalized: Runway Growth successfully closed its acquisition of SWK Holdings on April 6, 2026, for a total price of $249 million, comprising $75.5 million in Runway Growth shares and $173.5 million in cash, enhancing the company's investment capabilities and earnings potential.
- Portfolio Expansion: Following the acquisition, Runway Growth's total assets will reach $1.2 billion, with healthcare and life sciences investments increasing from 14% to approximately 32% as of December 31, 2025, accelerating the company's diversification in a rapidly growing market.
- Investment Activity Update: In Q1 2026, Runway Growth completed four investments totaling $17.6 million, including a new $7.5 million investment in HR Pharmaceuticals, demonstrating the company's ongoing commitment and growth potential in the medical products sector.
- Team Restructuring: David Spreng has returned as Chief Investment Officer, with the investment committee now including CFO Tom Raterman and BC Partners Credit partner Patrick Schafer, indicating a strategic reorganization and strengthening of leadership in investment management.
See More
Venture Debt Emerges as a Pillar of Startup Ecosystem
- Significant Venture Debt Growth: In 2025, U.S. venture debt reached a record $68.8 billion, while annual deal volume remained stable at around 1,000 transactions, indicating the increasing strategic importance of venture debt within the startup ecosystem.
- Investment Concentration in AI: U.S. venture investments totaled $321.6 billion in 2025, with 63.5% of deal value concentrated in artificial intelligence, reflecting a market preference for high-quality companies and an emphasis on capital efficiency.
- Flexible Financing Tool: High-quality companies are increasingly using venture debt as a strategic financing tool to extend flexibility, preserve ownership, and support growth without overly relying on dilutive equity capital.
- Future Outlook: The report predicts that venture debt will continue to play a larger role in 2026 as equity markets remain concentrated, serving as an efficient means for companies to finance growth, highlighting venture debt's dual role as a source of discipline and strategic advantage.
See More
Runway Growth Finance Corp. Q1 2026 Earnings Insights
- Acquisition Integration Progress: Runway Growth successfully completed the SWK acquisition in Q1 2026, with CEO David Spreng stating that this transaction will enhance the company's position in healthcare and further diversify its portfolio, although it faces near-term pressure from non-accrual loans.
- Leadership Changes: The company announced several executive appointments, including JD Tamas as Managing Director of Healthcare and Life Sciences Investing and Avisha Khubani promoted to Chief Credit Officer, indicating a strategic focus on key areas and talent deployment.
- Financial Performance Overview: In the first quarter, total investment income was $29.5 million and net investment income was $10.6 million, despite facing non-accrual status for loans from Marley Spoon and BlueShift, which raised the risk rating to 2.67, reflecting pressure on the investment portfolio.
- Future Outlook and Dividend Policy: Management expects the SWK portfolio to begin positively impacting EPS in Q2, although the non-accrual effects from Marley Spoon and BlueShift will offset some earnings; the board will continue to evaluate future dividend policies to maintain stability.
See More
Runway Growth Finance Reports Q1 Highlights
- Net Investment Income: Runway Growth Finance reported a net investment income of $0.29 for Q1, indicating stability in portfolio management despite a complex market environment, thus maintaining positive returns.
- Portfolio Size: The total fair value of the investment portfolio reached $886.3 million as of the reporting date, reflecting effective capital allocation and enhancing the company's competitive position in the industry.
- Yield Performance: The dollar-weighted annualized yield on debt investments stood at 14.2%, demonstrating successful risk management and providing shareholders with attractive return expectations, thereby boosting investor confidence.
- Investment Activity: The company completed four investments totaling $17.6 million in both new and existing portfolio companies, showcasing its proactive investment strategy and keen market opportunity recognition, further driving business growth.
See More
Runway Growth Capital Expands Credit Leadership with Key Appointments
- Credit Leadership Enhancement: Avisha Khubani has been promoted to Chief Credit Officer, overseeing Runway's credit functions including portfolio monitoring and risk management, which is expected to enhance the execution of the company's credit strategy.
- Focus on Healthcare: John D. Tamas has been appointed as Managing Director, concentrating on the healthcare and life sciences sectors, aiming to expand the firm's industry capabilities and network through his extensive investment experience.
- Experienced Team: Khubani has worked at Runway for eight years, previously serving as Managing Director of Portfolio Analytics, bringing deep expertise in portfolio valuation and management, which is anticipated to further improve the quality of the company's investment decisions.
- Strategic Growth Objectives: Runway aims to support fast-growing companies by providing senior loans ranging from $10 million to $150 million, and the appointments of Khubani and Tamas are expected to facilitate this goal, driving the company's expansion in the healthcare and life sciences sectors.
See More
Runway Growth Finance Corp. to Release Q1 2026 Financial Results
- Earnings Release Schedule: Runway Growth Finance Corp. will release its Q1 2026 financial results after market close on May 7, 2026, providing investors with insights into its latest financial status and operational performance.
- Conference Call Details: The company will hold a conference call on the same day at 2:00 PM PT (5:00 PM ET) to discuss the financial results, requiring investors to register in advance to ensure timely information dissemination.
- Webcast Replay Availability: A replay of the webcast will be available two hours after the call and archived on the same webpage for 90 days, allowing investors who cannot participate live to access the information later.
- Company Background: Runway Growth is a specialty finance company focused on providing flexible capital solutions to late- and growth-stage companies, aiming to offer alternatives to equity financing and enhance their market competitiveness.
See More
Runway Growth Completes Acquisition of SWK Holdings, Expanding Healthcare Focus
- Acquisition Finalized: Runway Growth successfully closed its acquisition of SWK Holdings on April 6, 2026, for a total price of $249 million, comprising $75.5 million in Runway Growth shares and $173.5 million in cash, enhancing the company's investment capabilities and earnings potential.
- Portfolio Expansion: Following the acquisition, Runway Growth's total assets will reach $1.2 billion, with healthcare and life sciences investments increasing from 14% to approximately 32% as of December 31, 2025, accelerating the company's diversification in a rapidly growing market.
- Investment Activity Update: In Q1 2026, Runway Growth completed four investments totaling $17.6 million, including a new $7.5 million investment in HR Pharmaceuticals, demonstrating the company's ongoing commitment and growth potential in the medical products sector.
- Team Restructuring: David Spreng has returned as Chief Investment Officer, with the investment committee now including CFO Tom Raterman and BC Partners Credit partner Patrick Schafer, indicating a strategic reorganization and strengthening of leadership in investment management.
See More
